{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:08:11Z","timestamp":1791378491171,"version":"4.3.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To assess the characteristics of patients with unilateral and bilateral tubo-ovarian abscess (TOA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Women diagnosed with TOA during 2003\u20132017 were included in this retrospective cohort study. TOA was diagnosed using sonography or computerized tomography and clinical criteria, or by surgical diagnosis. Demographics, sonographic data, clinical treatment, surgical treatment, and post-operative information were retrieved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study cohort included 144 women who met the inclusion criteria, of whom 78 (54.2%) had unilateral TOA and 66 (45.8%) had bilateral TOA. Baseline characteristics were not different between the groups. There was a statistical trend that women with fewer events of previous PID were less likely to have with bilateral TOA (75.3% vs. 64.1%, respectively; p\u2009=\u20090.074). Women diagnosed with bilateral TOA were more likely to undergo surgical treratment for bilateral salpingo-oophorectomy compared to unilateral TOA (61.5% vs. 42.3%, respectively; p\u2009=\u20090.04). There was no difference in maximum TOA size between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study detected a trend toward increased need for surgical treatment in women diagnosed with bilateral TOA. These findings may contribute to determining the optimal medical or surgical treatment, potentially leading to a decrease in the duration of hospitalization, antibiotic exposure, and resistance. However, it is important to acknowledge that the results of the current study are limited, and further research is warranted to validate these potential outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02826-x","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T08:03:09Z","timestamp":1702972989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bilateral or unilateral tubo-ovarian abscess: exploring its clinical significance"],"prefix":"10.1186","volume":"23","author":[{"given":"Yael","family":"Yagur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Weitzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gili","family":"Man-El","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yfat","family":"Kadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Daykan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Schonman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"key":"2826_CR1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra1411426","volume":"372","author":"RC Brunham","year":"2015","unstructured":"Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory Disease. N Engl J Med. 2015;372:2039\u201348.","journal-title":"N Engl J Med"},{"key":"2826_CR2","doi-asserted-by":"crossref","unstructured":"Kim HY, Yang JI, Moon C. Comparison of severe pelvic inflammatory Disease, pyosalpinx and tubo-ovarian abscess. J Obstet Gynecol Res. 2015;41.","DOI":"10.1111\/jog.12617"},{"key":"2826_CR3","unstructured":"Beigi RH. Epidemiology, clinical manifestations, and diagnosis of tubo-ovarian abscess. Up to date. 2017."},{"key":"2826_CR4","doi-asserted-by":"crossref","unstructured":"Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis, and management of severe pelvic inflammatory Disease and tuboovarian abscess. Clin Obstet Gynecol. 2012;55.","DOI":"10.1097\/GRF.0b013e3182714681"},{"key":"2826_CR5","doi-asserted-by":"crossref","unstructured":"Sordia-Hern\u00e1ndez LH, Serrano Castro LG, Sordia-Pi\u00f1eyro MO, Morales Martinez A, Sepulveda Orozco MC, Guerrero-Gonzalez G. Comparative study of the clinical features of patients with a tubo-ovarian abscess and patients with severe pelvic inflammatory Disease. Int J Gynecol Obstet. 2016;132.","DOI":"10.1016\/j.ijgo.2015.06.038"},{"key":"2826_CR6","doi-asserted-by":"crossref","unstructured":"Munro K, Gharaibeh A, Nagabushanam S, Martin C. Diagnosis and management of tubo-ovarian abscesses. Volume 20. The Obstetrician & Gynaecologist; 2018.","DOI":"10.1111\/tog.12447"},{"issue":"7 Pt 2","key":"2826_CR7","first-page":"1055","volume":"138","author":"DS Ginsburg","year":"1980","unstructured":"Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR. Tubo-ovarian abscess: a retrospective review. YMOB. 1980;138(7 Pt 2):1055\u20138.","journal-title":"YMOB"},{"key":"2826_CR8","doi-asserted-by":"crossref","unstructured":"Unemo M, Bradshaw CS, Hocking JS, de Vries HJC, Francis SC, Mabey D et al. Sexually transmitted Infections: challenges ahead. Lancet Infect Dis. 2017.","DOI":"10.1016\/S1473-3099(17)30310-9"},{"key":"2826_CR9","doi-asserted-by":"publisher","unstructured":"Global incidence and prevalence of selected curable sexually transmitted infections. 2008. Reprod Health Matters. 2012. https:\/\/doi.org\/10.1016\/s0968-8080(12)40660-7.","DOI":"10.1016\/s0968-8080(12)40660-7"},{"key":"2826_CR10","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control. Sexually Transmitted Disease Surveillance. 2017. Centre of Disease Control and Prevention. 2017. https:\/\/doi.org\/10.1016\/j.molmet.2013.04.004.","DOI":"10.1016\/j.molmet.2013.04.004"},{"key":"2826_CR11","doi-asserted-by":"publisher","DOI":"10.1177\/0956462417744099","author":"J Ross","year":"2018","unstructured":"Ross J, Guaschino S, Cusini M, Jensen J. 2017 European guideline for the management of pelvic inflammatory Disease. Int J STD AIDS. 2018. https:\/\/doi.org\/10.1177\/0956462417744099.","journal-title":"Int J STD AIDS"},{"key":"2826_CR12","doi-asserted-by":"crossref","unstructured":"Romosan G, Valentin L. The sensitivity and specificity of transvaginal ultrasound with regard to acute pelvic inflammatory Disease: a review of the literature. Arch Gynecol Obstet. 2014;289.","DOI":"10.1007\/s00404-013-3091-6"},{"key":"2826_CR13","doi-asserted-by":"crossref","unstructured":"Revzin Mv, Mathur M, Dave HB, Macer ML, Spektor M. Pelvic inflammatory Disease: multimodality imaging approach with clinical-pathologic correlation. Radiographics. 2016;36.","DOI":"10.1148\/rg.2016150202"},{"key":"2826_CR14","unstructured":"Curry A, Williams T, Penny ML. Pelvic inflammatory Disease: diagnosis, management, and prevention. Am Fam Physician. 2019;100."},{"key":"2826_CR15","doi-asserted-by":"crossref","unstructured":"Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory Disease and infertility. Obstet Gynecol. 2012;120.","DOI":"10.1097\/AOG.0b013e31825a6bc9"},{"key":"2826_CR16","doi-asserted-by":"crossref","unstructured":"McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB, Levine E et al. Medically sound, cost-effective treatment for pelvic inflammatory Disease and tuboovarian abscess. In: Am J Obstet Gynecol. 1998. p. 1272\u20138.","DOI":"10.1016\/S0002-9378(98)70333-3"},{"key":"2826_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.ajog.2005.06.019","volume":"193","author":"K Gjelland","year":"2005","unstructured":"Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol. 2005;193:1323\u201330.","journal-title":"Am J Obstet Gynecol"},{"key":"2826_CR18","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bpobgyn.2009.01.010","volume":"23","author":"S Granberg","year":"2009","unstructured":"Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009;23:667\u201378.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2826_CR19","doi-asserted-by":"crossref","unstructured":"Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv. 2009;64.","DOI":"10.1097\/OGX.0b013e3181b8b0d6"},{"key":"2826_CR20","doi-asserted-by":"crossref","unstructured":"Akselim B, Kara\u015fin SS, Demirci A, \u00dcst\u00fcnyurt E. Can antibiotic treatment failure in tubo-ovarian abscess be predictable? Eur J Obstet Gynecol Reproductive Biology. 2021;258.","DOI":"10.1016\/j.ejogrb.2021.01.011"},{"key":"2826_CR21","doi-asserted-by":"crossref","unstructured":"Yang CC, Chen P, Tseng JY, Wang PH. Advantages of open laparoscopic Surgery over exploratory laparotomy in patients with tubo-ovarian abscess. J Am Association Gynecologic Laparoscopists. 2002;9.","DOI":"10.1016\/S1074-3804(05)60412-4"},{"key":"2826_CR22","unstructured":"Bugg CW, Taira T. Pelvic inflammatory Disease: diagnosis and treatment in the Emergency Department. Emerg Med Pract. 2016;18."},{"key":"2826_CR23","unstructured":"Greenstein Y, Shah AJ, Vragovic O, Cabral H, Soto-Wright V, Borgatta L et al. Tuboovarian abscess: factors associated with operative intervention after failed antibiotic therapy. J Reprod Med. 2013;58."},{"key":"2826_CR24","doi-asserted-by":"crossref","unstructured":"Fouks Y, Cohen A, Shapira U, Solomon N, Almog B, Levin I. Surgical intervention in patients with tubo-ovarian abscess: clinical predictors and a simple risk score. J Minim Invasive Gynecol. 2019;26.","DOI":"10.1016\/j.jmig.2018.06.013"},{"key":"2826_CR25","doi-asserted-by":"crossref","unstructured":"Hwang JH, Kim BW, Kim SR, Kim JH. The prediction of surgical intervention in patients with tubo-ovarian abscess. J Obstet Gynaecol (Lahore). 2022;42.","DOI":"10.1080\/01443615.2020.1867965"},{"key":"2826_CR26","doi-asserted-by":"crossref","unstructured":"Chan GMF, Fong YF, Ng KL. Tubo-Ovarian Abscesses: Epidemiology and Predictors for Failed Response to Medical Management in an Asian Population. Infect Dis Obstet Gynecol. 2019;2019.","DOI":"10.1155\/2019\/4161394"},{"key":"2826_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000072076","volume":"55","author":"R Halperin","year":"2003","unstructured":"Halperin R, Levinson O, Yaron M, Bukovsky I, Schneider D. Tubo-ovarian abscess in older women: is the woman\u2019s age a risk factor for failed response to Conservative treatment? Gynecol Obstet Invest. 2003;55:211\u20135. https:\/\/doi.org\/10.1159\/000072076.","journal-title":"Gynecol Obstet Invest"},{"key":"2826_CR28","doi-asserted-by":"crossref","unstructured":"Demirtas O, Akman L, Demirtas GS, Hursitoglu BS, Yilmaz H. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory Disease: a single-center 5-year experience. Arch Gynecol Obstet. 2013;287.","DOI":"10.1007\/s00404-012-2600-3"},{"key":"2826_CR29","doi-asserted-by":"crossref","unstructured":"Zhu S, Ballard E, Khalil A, Baartz D, Amoako A, Tanaka K. Impact of early surgical management on tubo-ovarian abscesses. J Obstet Gynaecol (Lahore). 2021;41.","DOI":"10.1080\/01443615.2020.1821620"},{"key":"2826_CR30","doi-asserted-by":"crossref","unstructured":"Workowski KA. Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2015;61.","DOI":"10.1093\/cid\/civ771"},{"key":"2826_CR31","doi-asserted-by":"crossref","unstructured":"Tugrul Ersak D, Ersak B, Kokanal\u0131 MK. The effect of intrauterine device presence and other factors in medical treatment success of tuboovarian abscess. J Gynecol Obstet Hum Reprod. 2021;50.","DOI":"10.1016\/j.jogoh.2020.101983"},{"key":"2826_CR32","doi-asserted-by":"crossref","unstructured":"Landers DV, Sweet RL. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis. 1983;5.","DOI":"10.1093\/clinids\/5.5.876"},{"key":"2826_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.idc.2008.05.008","volume":"22","author":"SM Lareau","year":"2008","unstructured":"Lareau SM, Beigi RH. Pelvic inflammatory Disease and tubo-ovarian abscess. Infect Dis Clin N Am. 2008;22:693\u2013708.","journal-title":"Infect Dis Clin N Am"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02826-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02826-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02826-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T20:02:47Z","timestamp":1703016167000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02826-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2826"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02826-x","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"2 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the Meir Medical Center Ethics Committee, approval number MMC-082-17. Due to the retrospective nature of the study, Meir Medical Center Ethics Committee has waived need for informed consent statement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"678"}}